LabStart New Mexico

  • Introducing Martin Piltch, co-inventor of the Surround Optical Fiber Immunoassay Technology (SOFIA) that was recently licensed from LANL by Bionosis, Inc.

Strategy

Identify innovative technologies in collaboration with the Technology Transfer group at Los Alamos

Los Alamos National Laboratory provides the United States with the best technical solutions to problems of national importance. A number of these solutions have applications relevant to private markets. LabStart seeks to identify and learn as much about the Laboratory’s R&D efforts for the government and investigates which of these have market applications and potential.

Assess technology, applications, markets, needs, suitability for commercialization

While Los Alamos’ technology have clear national security solutions in many cases, market applications are not as distinct. LabStart seeks to understand technology potential and explores possible applications and opportunities within the market.

Provide linkages to large corporations and investors with vetted sets of technologies

The Laboratory has a substantial amount of research spanning a significant amount of science and technology, the research is not at an “investment-grade” status necessary to interest private companies to license or to interest investors to back a start-up initiative. LabStart prepares and invests in top research efforts that will most likely reach expectations of corporations and investors alike.